Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/s-0042-110176
Discharge hemoglobin and outcome in patients with acute nonvariceal upper gastrointestinal bleeding
Publication History
submitted21 December 2015
accepted after revision23 May 2016
Publication Date:
21 July 2016 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00025476/201608/lookinside/thumbnails/479_10-1055-s-0042-110176-1.jpg)
Background and study aims: Many patients with acute gastrointestinal bleeding present with anemia and frequently require red blood cell (RBC) transfusion. A restrictive transfusion strategy and a low hemoglobin (Hb) threshold for transfusion had been shown to produce acceptable outcomes in patients with acute upper gastrointestinal bleeding. However, most patients are discharged with mild anemia owing to the restricted volume of packed RBCs (pRBCs). We investigated whether discharge Hb influences the outcome in patients with acute nonvariceal upper gastrointestinal bleeding.
Patients and methods: We retrospectively analyzed patients with upper gastrointestinal bleeding who had received pRBCs during hospitalization between January 2012 and January 2014. Patients with variceal bleeding, malignant lesion, stroke, or cardiovascular disease were excluded. We divided the patients into 2 groups, low (8 g/dL ≤ Hb < 10 g/dL) and high (Hb ≥ 10 [g/dL]) discharge Hb, and compared the clinical course and Hb changes between these groups.
Results: A total of 102 patients met the inclusion criteria. Fifty patients were discharged with Hb levels < 10 g/dL, whereas 52 were discharged with Hb levels > 10 g/dL. Patients in the low Hb group had a lower consumption of pRBCs and shorter hospital stay than did those in the high Hb group. The Hb levels were not fully recovered at outpatient follow-up until 7 days after discharge; however, most patients showed Hb recovery at 45 days after discharge. The rate of rebleeding after discharge was not significantly different between the 2 groups.
Conclusions: In patients with acute upper gastrointestinal bleeding, a discharge Hb between 8 and 10 g/dL was linked to favorable outcomes on outpatient follow-up. Most patients recovered from anemia without any critical complication within 45 days after discharge.
* These authors contributed equally.
-
References
- 1 van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol 2008; 22: 209-224
- 2 Rockall TA, Logan RF, Devlin HB et al. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom: Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 1995; 311: 222-226
- 3 Carson JL, Hill S, Carless P et al. Transfusion triggers: a systematic review of the literature. Transfusion Med Rev 2002; 16: 187-199
- 4 Villanueva C, Colomo A, Bosch A et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 1-21
- 5 Rockey DC. To transfuse or not to transfuse in upper gastrointestinal hemorrhage? That is the question. Hepatology 2014; 60: 422-424
- 6 Barkun AN, Bardou M, Kuipers EJ et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010; 152: 101-113
- 7 Edwards J, Morrison C, Mohiuddin M et al. Patient blood transfusion management: discharge hemoglobin level as a surrogate marker for red blood cell utilization appropriateness. Transfusion 2012; 52: 2445-2451
- 8 Sanders DS, Carter MJ, Goodchap RJ et al. Prospective validation of the Rockall risk scoring system for upper GI hemorrhage in subgroups of patients with varices and peptic ulcers. The Am Journal Gastroenterol 2002; 97: 630-635
- 9 Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet 2000; 356: 1318-1321
- 10 Society of Thoracic Surgeons Blood Conservation Guideline Task Force . Ferraris VA, Brown JR et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2 2011; 91: 944-982
- 11 Amsterdam EA, Wenger NK, Brindis RG et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 130: 2354-2394
- 12 Diedler J, Sykora M, Hahn P et al. Low hemoglobin is associated with poor functional outcome after non-traumatic, supratentorial intracerebral hemorrhage. Crit Care 2010; 14: 63
- 13 Sabatine MS, Morrow DA, Giugliano RP et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005; 111: 2042-2049
- 14 Holst LB, Haase N, Wetterslev J et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014; 371: 1381-1391
- 15 Carson JL, Sieber F, Cook DR et al. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet 2015; 385: 1183-1189
- 16 Vlaar AP, Hofstra JJ, Determann RM et al. The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. Blood 2011; 117: 4218-4225
- 17 Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009; 113: 3406-3417
- 18 Koch CG, Li L, Sessler DI et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-1239
- 19 Miller RD, Robbins TO, Tong MJ et al. Coagulation defects associated with massive blood transfusions. Ann Surg 1971; 174: 794-801
- 20 Reed RL II, Ciavarella D, Heimbach DM et al. Prophylactic platelet administration during massive transfusion: a prospective, randomized, double-blind clinical study. Ann Surg 1986; 203: 40-48
- 21 Ginn JL, Ducharme J. Recurrent bleeding in acute upper gastrointestinal hemorrhage: transfusion confusion. Can J Emerg Med 2001; 3: 193-198
- 22 Wang J, Bao YX, Bai M et al. Restrictive vs liberal transfusion for upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. World J Gastroenterol 2013; 19: 6919-6927
- 23 Hearnshaw SA, Logan RF, Palmer KR et al. Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 2010; 32: 215-224
- 24 Jairath V, Kahan BC, Logan RF et al. Red blood cell transfusion practice in patients presenting with acute upper gastrointestinal bleeding: a survey of 815 UK clinicians. Transfusion 2011; 51: 1940-1948
- 25 Bager P, Dahlerup JF. Patient-reported outcomes after acute nonvariceal upper gastrointestinal hemorrhage. Scand J Gastroenterol 2014; 49: 909-916